A new GLP-1 medication demonstrated efficacy in reducing blood sugar in people with type 2 diabetes in a phase 2b clinical trial
In this fully updated guide, we explore how Retatrutide works, what the new TRIUMPH-1 data tells us, its potential uses, possible side effects, UK availability timelines, and how it compares to well-known treatments such as Wegovy and Mounjaro
Type 2 diabetes, and cancer risk
Contraindications There are a few situations where GHK-Cu should be avoided
Hunger and food intake may increase after treatment stops, and some weight regain is common
En priode COVID, un auto-test antignique de dpitage sera obligatoire votre retour et donnera lieu une facturation de 8